Literature DB >> 2649989

The use of QALYs in health care decision making.

G Loomes1, L McKenzie.   

Abstract

This paper seeks to highlight some of the critical issues concerning the use of the Quality Adjusted Life Years (QALYs) to measure the outcome of health care choices, in decisions related to both individual patient care and social resource allocation. Much of the support for the QALY is based on its simplicity as a tool for resolving complex choices. However, it may be the case that the QALY is not sufficiently refined or robust, failing perhaps to take into account some of the critical factors which affect preferences over different health care scenarios.

Entities:  

Mesh:

Year:  1989        PMID: 2649989     DOI: 10.1016/0277-9536(89)90030-0

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  53 in total

1.  Culture, self-rated health and resource allocation decision-making.

Authors:  V L Wiseman
Journal:  Health Care Anal       Date:  1999

Review 2.  Benefit valuation in economic evaluation of cancer therapies. A systematic review of the published literature.

Authors:  J Brown; M Sculpher
Journal:  Pharmacoeconomics       Date:  1999-07       Impact factor: 4.981

Review 3.  Valuing health-related quality of life. A review of health state valuation techniques.

Authors:  C Green; J Brazier; M Deverill
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

4.  Oncologists' use of quality of life information: results of a survey of Eastern Cooperative Oncology Group physicians.

Authors:  A Bezjak; P Ng; R Skeel; A D Depetrillo; R Comis; K M Taylor
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

Review 5.  On individual preferences and aggregation in economic evaluation in healthcare.

Authors:  B Liljas; B Lindgren
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 6.  Common errors and controversies in pharmacoeconomic analyses.

Authors:  S Byford; S Palmer
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

7.  Palliative care for the terminally ill in America: the consideration of QALYs, costs, and ethical issues.

Authors:  Y Tony Yang; Margaret M Mahon
Journal:  Med Health Care Philos       Date:  2012-11

8.  Quality of life related to fear of falling and hip fracture in older women: a time trade off study.

Authors:  G Salkeld; I D Cameron; R G Cumming; S Easter; J Seymour; S E Kurrle; S Quine
Journal:  BMJ       Date:  2000-02-05

9.  The Australian Guidelines for subsidisation of pharmaceuticals: the road to cost-effective drug prescribing?

Authors:  M Johannesson
Journal:  Pharmacoeconomics       Date:  1992-11       Impact factor: 4.981

10.  Preference based outcome measures for economic evaluation of drug interventions: quality adjusted life years (QALYs) versus healthy years equivalents (HYEs).

Authors:  A Mehrez; A Gafni
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.